India Urges Reluctant MNCs To Launch New Drugs In Country
This article was originally published in PharmAsia News
The Indian government is urging multinational pharmaceutical companies to launch their new drugs in India, most of them for the first time since 1995. Some MNCs stopped marketing their drugs in India because of a fear that local generics makers would make illegal copies of MNC drugs. Some drug industry insiders believe India would have to improve its patent laws before MNCs could be enticed to launch their new drugs in the country. They point to Roche and Pfizer, who have lawsuits pending in court, claiming infringement of their patents by generic companies copying recently launched products. (Click here for more
You may also be interested in...
GSK is transferring technology to make its malaria vaccine antigen to Bharat Biotech and by 2029 will also transfer rights to supply the vaccine to WHO-approved immunization programs. The deal is expected to improve access via lower cost of the vaccine for such programs
Rules covering OTC medical devices, herbals and online activities have been added for the first time to the Irish Pharmaceutical Healthcare Association's Self-Care Advertising Code.
HBW Insight extracts five key lessons from 2020, the year the coronavirus pandemic swept its way across Europe.